Recombinant Danio rerio Prepro-urotensin II-beta (uts2b) is a recombinant protein derived from zebrafish, a species widely used in biomedical research due to its genetic similarity to humans and its rapid breeding cycle. This protein is part of the urotensin II family, which plays significant roles in cardiovascular function, inflammation, and potentially in the development of spinal morphology.
Urotensin II is a cyclic peptide originally identified in fish but later found in mammals as well. It signals through G-protein-coupled receptors and has been linked to cardiovascular diseases and other physiological processes. In zebrafish, urotensin II-related peptides like Urp1 and Urp2 have been shown to influence spine morphology by maintaining its structure and preventing abnormal curvatures during growth .
The recombinant Danio rerio Prepro-urotensin II-beta (uts2b) protein is available in various expression systems, including yeast, E. coli, baculovirus, and mammalian cells . This diversity in expression systems allows researchers to choose the most suitable form for their specific applications, whether it be for biochemical assays, structural studies, or functional analyses.
Expression System | Source | Features |
---|---|---|
Yeast | CSB-YP801894DIL | Suitable for large-scale production |
E. coli | CSB-EP801894DIL | Cost-effective, high yield |
E. coli (Biotinylated) | CSB-EP801894DIL-B | Avi-tag biotinylated for specific binding assays |
Baculovirus | CSB-BP801894DIL | High expression levels in insect cells |
Mammalian cell | CSB-MP801894DIL | Native-like post-translational modifications |
Future studies on Recombinant Danio rerio Prepro-urotensin II-beta (uts2b) could explore its signaling pathways and interactions with other proteins involved in spinal development. Additionally, comparing its function across different species could provide insights into evolutionary conservation and potential therapeutic targets.
KEGG: dre:402853
UniGene: Dr.24977
The stability and shelf life of recombinant uts2b depend on several factors including storage state, buffer ingredients, and storage temperature. For optimal preservation of protein integrity, the following guidelines should be followed:
Form | Storage Temperature | Shelf Life | Notes |
---|---|---|---|
Liquid | -20°C/-80°C | 6 months | Avoid repeated freeze-thaw cycles |
Lyophilized | -20°C/-80°C | 12 months | Preferred for long-term storage |
Working aliquots | 4°C | Up to one week | For immediate use |
Repeated freezing and thawing should be avoided as it can lead to protein degradation and loss of activity . It is advisable to prepare small working aliquots that can be stored at 4°C for up to one week to minimize freeze-thaw cycles while maintaining experimental consistency .
For proper reconstitution of uts2b, follow this methodological approach:
Briefly centrifuge the vial prior to opening to bring the contents to the bottom
Reconstitute the protein in deionized sterile water to achieve a concentration of 0.1-1.0 mg/mL
Add glycerol to a final concentration of 5-50% (50% is the standard recommendation)
Prepare small aliquots for long-term storage at -20°C/-80°C
This protocol minimizes protein denaturation while ensuring sample homogeneity . The addition of glycerol serves as a cryoprotectant that helps maintain protein structure during freezing and thawing processes. When designing experiments, it is important to consider the potential effects of glycerol on your experimental system, especially for functional assays where buffer components may influence outcomes.
Several analytical techniques should be employed to verify the identity and integrity of recombinant uts2b:
SDS-PAGE Analysis: Confirms the molecular weight and purity (>85% for commercial preparations)
Western Blotting: Verifies protein identity using specific antibodies
Mass Spectrometry: Provides precise molecular weight confirmation and can detect post-translational modifications
Sequence Verification: N-terminal sequencing confirms the correct processing of the mature protein
Functional Assays: Activity tests specific to urotensin II signaling pathways
These quality control measures ensure experimental reproducibility and valid research outcomes. For collaborative projects or publication purposes, it is advisable to document these verification steps to strengthen the reliability of your findings.
Zebrafish uts2b (Prepro-urotensin II-beta) represents one of the evolutionary variants of the urotensin II system found in teleost fish. When conducting comparative studies, researchers should note:
Species | Protein Features | Sequence Homology | Functional Conservation |
---|---|---|---|
Zebrafish (Danio rerio) | Two paralogs: uts2a and uts2b | Reference | Dual system with potentially divergent functions |
Human | Single UTS2 gene | Moderate conservation in mature peptide | Potent vasoactive peptide |
Mouse/Rat | Single Uts2 gene | Moderate conservation | Model organism for mammalian studies |
Other teleosts | Often multiple paralogs | Variable | Species-specific adaptations |
Cross-species research requires careful consideration of these evolutionary differences when interpreting experimental results and designing functional assays . The presence of two paralogs in zebrafish (uts2a and uts2b) may indicate subfunctionalization or neofunctionalization following the teleost-specific genome duplication event, creating unique research opportunities for studying the evolution of peptide hormone systems.
Designing effective perturbation experiments to study uts2b function requires a systematic approach:
Genetic Perturbation Methods:
CRISPR/Cas9 knockout: Design guide RNAs targeting uts2b exons
Morpholino knockdown: Target splice junctions or translation start sites
Overexpression: Inject mRNA encoding full-length or processed uts2b forms
Experimental Controls:
Include both positive controls (known phenotypes) and negative controls (non-targeting interventions)
Use paralog-specific interventions to distinguish between uts2a and uts2b functions
Implement rescue experiments to confirm specificity
Phenotypic Analysis Pipeline:
Temporal assessment: Examine effects at multiple developmental stages
Spatial analysis: Perform in situ hybridization to detect expression changes
Functional readouts: Measure physiological parameters (heart rate, vascular development)
Molecular Profiling:
Perform RNA-seq to identify differentially expressed genes
Use phosphoproteomics to detect signaling pathway alterations
Implement ChIP-seq to identify downstream transcriptional effects
These perturbation experiments should be designed with appropriate statistical power to detect biologically relevant effects while minimizing false discoveries . The analysis should account for both direct and indirect effects of uts2b perturbation on developmental processes.
When analyzing differential gene expression in response to uts2b perturbation, researchers should implement the following methodological framework:
Experimental Design Considerations:
Include biological replicates (minimum n=3) to account for natural variation
Control for batch effects in sequencing and sample preparation
Consider cell type-specific effects using single-cell approaches
Include time-course experiments to capture dynamic responses
Statistical Analysis Approach:
Apply rigorous statistical tests (e.g., Wilcoxon signed-rank test) to identify differentially expressed genes (DEGs)
Set appropriate cutoffs based on adjusted p-values and fold change
Verify consistency across biological replicates to ensure reliability
Account for technical noise inherent in expression measurements
Data Integration Strategies:
Leverage knowledge graphs to contextualize findings
Compare results across different cell lines or developmental stages
Integrate with protein-protein interaction networks
Validation Methods:
Confirm key findings with qRT-PCR
Perform protein-level validation via Western blotting
Use in situ hybridization to verify spatial expression patterns
This comprehensive approach allows for robust identification of genes affected by uts2b perturbation, distinguishing between direct targets and secondary effects . Given that individual gene measurements may be unreliable due to biological and technical noise, statistical analyses at the pathway or gene set level are often more informative for biological interpretation.
Computational modeling of uts2b mutations involves a multi-tiered approach:
Structural Modeling:
Generate 3D protein structure using homology modeling or AlphaFold2 predictions
Implement molecular dynamics simulations to assess structural stability
Perform in silico mutagenesis to predict effects on protein folding
Sequence-Based Predictions:
Identify conserved residues through multiple sequence alignment
Apply SIFT, PolyPhen, or PROVEAN algorithms to predict mutation impacts
Calculate evolutionary conservation scores to prioritize functionally important residues
Interaction Network Analysis:
Model protein-protein interactions affected by mutations
Predict alterations in binding affinity to receptors
Simulate downstream signaling pathway perturbations
Integrative Approach:
Combine structural, sequence, and network predictions
Validate computational predictions with experimental data
Refine models iteratively based on experimental feedback
This computational framework provides testable hypotheses about mutation effects that can guide experimental design, particularly for site-directed mutagenesis studies aimed at understanding structure-function relationships in uts2b . The integration of multiple computational approaches increases prediction accuracy and biological relevance.
Differentiating between the functions of uts2a and uts2b paralogs requires complementary experimental strategies:
Paralog-Specific Genetic Perturbations:
Generate single and double knockout lines (uts2a-/-, uts2b-/-, uts2a-/-;uts2b-/-)
Design paralog-specific morpholinos targeting unique sequence regions
Create rescue constructs expressing only one paralog
Expression Pattern Analysis:
Perform dual-color in situ hybridization to visualize co-expression or distinct expression domains
Generate transgenic reporter lines (uts2a:GFP, uts2b:RFP) to track expression dynamics
Quantify relative expression levels across developmental stages and tissues
Functional Complementation Tests:
Cross-rescue experiments (can uts2a rescue uts2b phenotypes and vice versa?)
Domain-swapping experiments to identify functionally distinct protein regions
Receptor binding assays to determine ligand specificity
Transcriptomic Profiling:
Compare transcriptional responses to individual paralog perturbations
Identify unique and shared downstream targets
Perform gene set enrichment analysis to determine pathway specificity
This multi-faceted approach enables researchers to delineate the distinct biological roles of these paralogs, providing insights into the evolutionary divergence of gene function following duplication events . The comparison between paralogs can reveal fundamental principles of protein evolution and functional specialization.
Reconciling contradictory results in uts2b signaling requires systematic troubleshooting and contextual interpretation:
Sources of Experimental Variation:
Cell line or developmental stage differences may explain divergent results
Experimental conditions (temperature, medium composition) can influence signaling outcomes
Genetic background effects may modulate uts2b signaling
Methodological Reconciliation Approach:
Standardize experimental protocols across research groups
Implement meta-analysis of multiple datasets using consistent statistical methods
Develop consensus reporting standards for uts2b experiments
Biological Interpretation Framework:
Consider context-dependent signaling (cell type, developmental timing)
Evaluate compensatory mechanisms activated in different experimental systems
Assess potential cross-talk with other signaling pathways
Resolution Strategies:
Design definitive experiments addressing specific contradictions
Use orthogonal methodologies to validate key findings
Implement systems biology approaches to model complex pathway interactions
This structured approach transforms apparent contradictions into opportunities for deeper understanding of context-dependent signaling mechanisms . When analyzing conflicting data, researchers should consider both the technical aspects (experimental design, statistical power) and biological factors (compensatory mechanisms, cellular context) that might explain the observed differences.
Designing rigorous controls for uts2b functional assays is critical for experimental validity:
Control Type | Recommended Controls | Rationale | Limitations |
---|---|---|---|
Negative Controls | Heat-inactivated uts2b | Tests activity dependence on protein structure | May not control for contaminants |
Buffer-only treatment | Controls for vehicle effects | Does not account for non-specific protein effects | |
Scrambled peptide with same amino acid composition | Controls for amino acid-specific effects | May have unexpected bioactivity | |
Positive Controls | Commercial urotensin II peptide | Known bioactivity benchmark | May differ from full-length protein effects |
uts2a paralog (for comparative studies) | Evaluates paralog-specific functions | Different potency may complicate interpretation | |
Specificity Controls | uts2b pre-incubated with neutralizing antibody | Confirms signal is uts2b-dependent | Antibody may have incomplete neutralization |
Receptor antagonist co-treatment | Validates receptor-mediated effects | May have off-target effects |
These controls should be systematically included in experimental designs to enable confident interpretation of results . The selection of appropriate controls depends on the specific research question and experimental system, with particular attention to potential confounding factors.
The separation and individual study of cleaved uts2b forms requires specialized techniques:
Separation Methods:
High-Performance Liquid Chromatography (HPLC) with specific columns optimized for peptide separation
Size Exclusion Chromatography (SEC) to separate based on molecular size differences
Immunoaffinity purification using form-specific antibodies
Electrophoretic techniques optimized for small peptides
Verification Approaches:
Mass spectrometry to confirm identity and purity
N-terminal sequencing to verify correct processing
Western blotting with form-specific antibodies
Circular dichroism to assess secondary structure
Individual Form Expression:
Synthetic peptide production for the mature Urotensin II-beta
Recombinant expression of truncated constructs
Site-directed mutagenesis to prevent cleavage for studying Urophysin beta
Functional Characterization:
Receptor binding assays for individual forms
Signaling pathway activation comparison
Physiological response measurement (vasoconstriction, calcium flux)
This methodological approach enables researchers to dissect the potentially distinct functions of the cleaved products from the uts2b precursor . Separate characterization of these forms is particularly important since post-translational processing can dramatically alter bioactivity and receptor specificity.
Integration of uts2b perturbation data with other -omics datasets requires a structured analytical framework:
Multi-omics Data Integration Workflow:
Normalize data across platforms to enable direct comparisons
Implement dimensionality reduction techniques (PCA, t-SNE) to visualize relationships
Apply computational methods that account for different data types:
Network-based integration (weighted correlation networks)
Bayesian integration methods
Multi-block statistical approaches
Biological Knowledge Integration:
Map data to biological pathways using databases like Reactome
Leverage Gene Ontology annotations to identify functional enrichment
Incorporate protein-protein interaction networks from databases like STRING
Temporal and Spatial Integration:
Align developmental timepoints across datasets
Consider tissue/cell type-specific effects
Track dynamic changes in response to perturbation
Visualization Strategies:
Create integrative heatmaps showing patterns across datasets
Develop network visualizations highlighting key interactions
Implement interactive dashboards for data exploration
This integrative approach reveals emergent properties not evident in individual datasets, providing a systems-level understanding of uts2b function . When integrating datasets from different sources, careful attention must be paid to batch effects, technical variability, and differences in experimental design that might influence interpretation.
Managing biological variability in uts2b expression studies requires sophisticated statistical approaches:
Variance Component Analysis:
Quantify sources of variability (biological vs. technical)
Implement mixed-effects models to account for nested experimental designs
Calculate intraclass correlation coefficients to assess reliability
Robust Statistical Methods:
Apply non-parametric tests (e.g., Wilcoxon signed-rank test) when assumptions of normality are violated
Implement bootstrap resampling to estimate confidence intervals
Use permutation tests for hypothesis testing with small sample sizes
Bayesian Approaches:
Incorporate prior knowledge to improve inference
Implement hierarchical models to share information across related conditions
Calculate posterior probabilities for more nuanced interpretations
Multiple Testing Correction:
Apply appropriate correction methods (Benjamini-Hochberg, Bonferroni) for large-scale analyses
Implement q-value approaches to control false discovery rate
Consider the trade-off between Type I and Type II errors based on experimental goals
These statistical approaches improve the reliability and reproducibility of uts2b expression studies by properly accounting for the inherent biological variability present in living systems . The selection of appropriate statistical methods should be guided by the experimental design, sample size, and specific research questions being addressed.
Zebrafish uts2b research provides valuable translational insights through comparative approaches:
Cross-Species Comparative Analysis:
Identify conserved structural and functional domains between zebrafish uts2b and human urotensin II
Map zebrafish phenotypes to potential human disease manifestations
Compare receptor binding profiles and signaling pathway activation
Disease Modeling Approaches:
Generate zebrafish models mimicking human urotensin II system mutations
Validate phenotypes against known human pathologies (cardiovascular, metabolic, renal)
Perform high-throughput drug screening using zebrafish disease models
Mechanistic Insights Translation:
Determine if molecular mechanisms identified in zebrafish are conserved in human systems
Correlate gene expression patterns across species to identify conserved regulatory networks
Validate key findings in human cell lines or tissues
Therapeutic Development Pipeline:
Use zebrafish for initial screening of urotensin II pathway modulators
Identify potential biomarkers for human disease progression
Develop targeted therapeutic approaches based on conserved signaling nodes
This translational approach leverages the experimental advantages of zebrafish while maintaining focus on human health applications . When designing translational studies, researchers should critically evaluate both the similarities and differences between zebrafish and human systems to ensure appropriate interpretation of results.
Transitioning from zebrafish to mammalian models requires methodological adaptations:
Experimental Design Modifications:
Adjust developmental timeframes to account for species differences
Consider the absence of paralogs in mammalian systems (single UTS2 gene)
Adapt tissue collection and processing protocols for larger organisms
Implement tissue-specific conditional approaches for targeted studies
Analytical Considerations:
Recalibrate expression analysis parameters for mammalian reference genomes
Adjust statistical power calculations based on increased biological variability
Consider species-specific post-translational modifications and processing
Translation Validation Framework:
Parallel testing in both zebrafish and mammalian systems
Confirmation of key molecular interactions in mammalian cells
Cross-validation of phenotypes across model systems
Verification of drug responses in both zebrafish and mammalian models
Methodological Limitations to Consider:
Differences in bioavailability and pharmacokinetics between species
Variations in receptor distribution and density
Divergent physiological responses due to anatomical differences
Species-specific compensatory mechanisms
This structured transition approach ensures that insights gained from zebrafish studies are appropriately translated to mammalian systems, accounting for evolutionary divergence while leveraging conserved biology . Researchers should implement targeted validation experiments to confirm that mechanisms identified in zebrafish are conserved in mammalian models before proceeding to potential clinical applications.